Kemin Biologics

Kemin Biologics

Biotechnology Research

Des Moines, Iowa 1,960 followers

Striving to sustainably transform the quality of life every day for 80% of the world with our products and services.

About us

Kemin Biologics offers a wide portfolio of poultry biologicals that focus on Transboundary Control, Respiratory Integrity, Immunocompetence and Food Safety. The current portfolio of more than 40 poultry vaccines, targets a variety of diseases such as, avian influenza, Newcastle disease, infectious bronchitis, coryza, cholera and egg drop syndrome. In addition, it offers major vaccines for ruminant transboundary diseases, such as, a large selection of combinations for foot and mouth disease, lumpy skin disease, sheep pox, ruminant pest and rift valley fever. Kemin also offers a selection of specific aquaculture vaccines that target Streptococcosis, Lactococcosis, Enterococcosis and Vibriosis.

Website
https://www.kemin.com/eu/en/markets/vaccines
Industry
Biotechnology Research
Company size
1,001-5,000 employees
Headquarters
Des Moines, Iowa
Founded
1961
Specialties
vaccines, avian influenza, foot and mouth disease, food producing animals, biotechnology, infectious bronchitis, Lumpy Skin Disease, transformation, immunity, transboundary diseases, Newcastle Disease, and ND7

Updates

Affiliated pages

Similar pages